Repare Therapeutics
RPTX
RPTX
61 hedge funds and large institutions have $112M invested in Repare Therapeutics in 2024 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 21 increasing their positions, 17 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
33% less capital invested
Capital invested by funds: $167M → $112M (-$55.7M)
60% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 15
73% less call options, than puts
Call options by funds: $19K | Put options by funds: $70K
Holders
61
Holding in Top 10
4
Calls
$19K
Puts
$70K
Top Buyers
| 1 | +$1.07M | |
| 2 | +$933K | |
| 3 | +$825K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$572K |
| 5 |
Squarepoint
New York
|
+$383K |
Top Sellers
| 1 | -$5.87M | |
| 2 | -$3.3M | |
| 3 | -$1.62M | |
| 4 |
HS
HighVista Strategies
Boston,
Massachusetts
|
-$778K |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$318K |